+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hormone Drug"

Prediabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Prediabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Porphyria - Pipeline Insight, 2025 - Product Thumbnail Image

Porphyria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
Hyperphosphatemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hyperphosphatemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Somatostatin Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Somatostatin Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cushing Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Cushing Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pheochromocytoma- Pipeline Insight, 2025 - Product Thumbnail Image

Pheochromocytoma- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Male Hypogonadism - Pipeline Insight, 2025 - Product Thumbnail Image

Male Hypogonadism - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hyperparathyroidism - Pipeline Insight, 2025 - Product Thumbnail Image

Hyperparathyroidism - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Turner Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Turner Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Central Precocious Puberty - Pipeline Insight, 2025 - Product Thumbnail Image

Central Precocious Puberty - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Ghrelin Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Ghrelin Receptor Agonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Parathyroid Hormone Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Parathyroid Hormone Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dementia With Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Dementia With Diabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Graves' Orbitopathy- Pipeline Insight, 2025 - Product Thumbnail Image

Graves' Orbitopathy- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pediatric Growth Hormone Deficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Pediatric Growth Hormone Deficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adult-onset Growth Hormone Deficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Adult-onset Growth Hormone Deficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Hormone Drug market is a subset of the biotechnology industry that focuses on the development and production of drugs that target hormones. These drugs are used to treat a variety of conditions, including diabetes, obesity, infertility, and menopause. Hormone drugs are typically administered through injections, patches, or pills, and are designed to mimic the body's natural hormones. The hormone drug market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing ones. Additionally, many companies are investing in research and development to create more effective treatments. Notable companies in the hormone drug market include Novo Nordisk, Eli Lilly, Merck, Pfizer, and Sanofi. Show Less Read more